325 related articles for article (PubMed ID: 25303893)
21. MicroRNAs in heart failure: from biomarker to target for therapy.
Vegter EL; van der Meer P; de Windt LJ; Pinto YM; Voors AA
Eur J Heart Fail; 2016 May; 18(5):457-68. PubMed ID: 26869172
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in cardiovascular disease.
Gurha P
Curr Opin Cardiol; 2016 May; 31(3):249-54. PubMed ID: 26885771
[TBL] [Abstract][Full Text] [Related]
23. Small Molecules with Big Impacts on Cardiovascular Diseases.
Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
[TBL] [Abstract][Full Text] [Related]
24. Role of microRNAs in cardiac hypertrophy and heart failure.
Wang N; Zhou Z; Liao X; Zhang T
IUBMB Life; 2009 Jun; 61(6):566-71. PubMed ID: 19472179
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA Signature and Cardiovascular Dysfunction.
Arunachalam G; Upadhyay R; Ding H; Triggle CR
J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs: new players in heart failure.
Oliveira-Carvalho V; da Silva MM; Guimarães GV; Bacal F; Bocchi EA
Mol Biol Rep; 2013 Mar; 40(3):2663-70. PubMed ID: 23242657
[TBL] [Abstract][Full Text] [Related]
27. Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.
Wang F; Chen C; Wang D
Front Med; 2014 Dec; 8(4):404-18. PubMed ID: 25445171
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Biomarkers and Cardiovascular Disease: Circulating MicroRNAs.
de Gonzalo-Calvo D; Iglesias-Gutiérrez E; Llorente-Cortés V
Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):763-769. PubMed ID: 28623159
[TBL] [Abstract][Full Text] [Related]
29. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
Zhao G
J Med Genet; 2018 Nov; 55(11):713-720. PubMed ID: 30177556
[TBL] [Abstract][Full Text] [Related]
30. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs in cardiovascular diseases: biology and potential clinical applications.
Kartha RV; Subramanian S
J Cardiovasc Transl Res; 2010 Jun; 3(3):256-70. PubMed ID: 20560047
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs -the next generation therapeutic targets in human diseases.
Srinivasan S; Selvan ST; Archunan G; Gulyas B; Padmanabhan P
Theranostics; 2013 Nov; 3(12):930-42. PubMed ID: 24396504
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
Pan ZW; Lu YJ; Yang BF
Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs: Novel diagnostic and prognostic biomarkers in atherosclerosis.
Siasos G; Kollia C; Tsigkou V; Basdra EK; Lymperi M; Oikonomou E; Kokkou E; Korompelis P; Papavassiliou AG
Curr Top Med Chem; 2013; 13(13):1503-17. PubMed ID: 23745802
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential.
Shah P; Bristow MR; Port JD
Curr Heart Fail Rep; 2017 Dec; 14(6):454-464. PubMed ID: 28940102
[TBL] [Abstract][Full Text] [Related]
36. Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.
Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Torres-Granados C; Aguirre-Zamorano MA; Collantes-Estevez E; Pérez-Sánchez C
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32188016
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
[TBL] [Abstract][Full Text] [Related]
38. Identification of cardiovascular microRNA targetomes.
Fiedler J; Gupta SK; Thum T
J Mol Cell Cardiol; 2011 Nov; 51(5):674-81. PubMed ID: 21888912
[TBL] [Abstract][Full Text] [Related]
39. Noncoding RNAs in Cardiac Hypertrophy.
Li Y; Liang Y; Zhu Y; Zhang Y; Bei Y
J Cardiovasc Transl Res; 2018 Dec; 11(6):439-449. PubMed ID: 30171598
[TBL] [Abstract][Full Text] [Related]
40. Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling.
Zhou S; Liu Y; Prater K; Zheng Y; Cai L
Life Sci; 2013 Nov; 93(23):855-62. PubMed ID: 24021888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
